Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.79 by 1.27 percent. This is a 6.67 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $5.203 billion which beat the analyst consensus estimate of $5.170 billion by 0.64 percent. This is a 11.58 percent increase over sales of $4.663 billion the same period last year.